Our health is directly influenced by our immune system. A balanced and healthy immune system is of utmost importance for our body's ability to defend against infections. WHO proclaimed “It is our ability to create a healthy immune system that represents the greatest potential for gains in human Therefore, creating a healthy immune system via Mother’s 1st Milk: Colostrum & its derivatives harnesses maximum benefit towards human health”
New Immunity booster Drug having Nano informational peptides from Bovine Colostrum with Global Patents as Radha 108 was discovered after 15+years of basic research with the help of eminent group of scientists & doctors with relentless efforts by Dr Pawan Saharan, Founder CEO/ CSO, Biomix Inc. in collaboration with two time Nobel Prize winner, late Prof Dr George Wald,Harvard Medical School, Prof Joseph Weizenbaum, Father of AI, MIT Cambridge, Dr Suresh Advani, MD, Oncologist & Founder:Tata Memorial Cancer Hospital Mumbai and Dr C R Bhatia, Director: Biomedical research at Bhabha Atomic Research Center & Secretary Dept of Biotechnology, Govt of India.
Former President of India, Late Dr Abdul Kalam stated "while Fleming discovered Penicillin G, which saved millions from bacterial infections, Radha108 Immunity drug discovered by Dr Saharan, nominated for best scientist Award by Govt of India & American Association for the Advancement of Science will save billions from viral infections & immunity disorders.”
Mode of Action of Immunity Booster drug consists of Nanopeptides, originally derived from mammalian colostrum and now isolated and synthesised (like BMS's block buster anti cancer natural drug:Taxol) with vaccine like antiviral and immnomodulator property crossing the blood brain barrier (BBB) & sending signals via pituitary to thymus & bone marrow to build body’s immune system via release of cytokines, interleukins,interferon Gamma & Tumour Necrosis Factor along with attachment inhibition for all Viral particles on cell surface created a paradigm shift in Healthcare food & Pharma Industry via blocking cell surface receptor with vaccine like property.
United States, EU, Africa & Singapore approved this path breaking innovation for 58 indications targeting conditions like gut infections, muscle loss, Alzheimer’s, Chronic Fatigue Syndrome along with Crohn’s disease, ulcerative colitis, HIV, Swine Flue, TB, Cancer: Carcinoma, Type 2 diabetics, COPD: Allergy & Asthma, Autoimmune & Neural disorders : RA,, Parkinson, Nerve regeneration & Memory Enhancer (US Product Patent#9,249,188) and will enable human population to lead longer & healthier lives via building body’s own immune system naturally at affordable cost.
The Product has Medical confirmation with Global clinical studies conducted in the United States, Africa & Asia on 25,308 patients & healthy population of age group from infants to geriatric population proves that Immunity drug not only treats communicable & immunity disorders but also help prevent them on a Mass Scale and can be used for all age group
Global Clinical studies were conducted on Immunity Drug Radha 108 formulation Receptol oral spray in HIV + AIDS patients on stand alone mono therapy basis as a model for all Viral & Immunity disorders and a follow post the study was done for a period of 10 years showing it has treated AIDS patients fully with only 1 year of therapy compared to life Long ART.
The peer-reviewed publications for each indication along with MoA are listed in the Receptol book released by Govt of India Titled:
Health for all via Receptol
A Paradigm Shift in healthcare
We also have Medical devises Lab & Hospital on Chip with Patents in North America & Australia.
Dr. Pawan Saharan
Biomix Network Ltd, India, USA & UK
Copyright © BIOMIX NETWORK LTD